Participants 62 94 3
Ebola vaccine in healthy adults:
Participants 558 628 3
at the Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Participants 630 968 8
Participants (aged 18-65 years) were randomly assigned (2:2:1), via two computer-generated randomisation lists for individuals potentially deployed in endemic areas and those not deployed, to receive a single intramuscular dose of high-dose vaccine (5 × 10(10) viral particles), low-dose vaccine (2·5 × 10(10) viral particles),
Participants 1577 1813 6
.
FINDINGS Between Oct 24, 2014, and June 22, 2015, we randomly assigned 120 participants, of whom 18 (15%) were potentially deployed and 102 (85%) were non-deployed, to receive high-dose vaccine (n=49), low-dose vaccine (n=51), or plac
